Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 9484: Ferroptosis Inhibitors Reduce Brain Inflammation Due to Cardiac Ischemia/Reperfusion Injury in Rats

View through CrossRef
Introduction: Brain inflammation and microglial hyperactivation are involved in the process of neuronal death including apoptosis, necroptosis, and ferroptosis, following cardiac and cerebral ischemia/reperfusion (I/R) injury. However, the roles of these cell death inhibitors on brain inflammation and microglia following cardiac I/R injury have not been investigated. Hypothesis: Inhibitors of apoptosis, necroptosis and ferroptosis effectively attenuate brain inflammation and microglial hyperactivation in rats with cardiac I/R injury. Methods: Rats were subjected to either sham or cardiac I/R operation (30 min-ischemia followed by 120-min reperfusion). Rats in cardiac I/R group were divided into 4 treatment groups: 1) vehicle, 2) apoptosis inhibitor (Z-VAD; 3.3 mg/kg), 3) necroptosis inhibitor (necrostatin-1; Nec-1; 3.3 mg/kg), and 4) ferroptosis inhibitor (ferrostatin-1; Fer-1; 2 mg/kg). These drugs were given intravenously at 15 min before ischemia. Finally, the heart and brain tissues were removed and used to determine cardiac infarct size, hippocampal-microglial morphology, and levels of cortical inflammatory cytokines. Results: Cardiac I/R injury caused myocardial infarction and brain inflammation as indicated by increased cortical IL-1β mRNA level and hippocampal microglial hyperactivation. Treatment with Z-VAD and Fer-1, but not Nec-1, reduced myocardial infarction and cortical IL-1β mRNA level. Z-VAD and Fer-1 also increased microglial process length and decreased microglial volume. Nec-1 increased microglial process length, but it did not decrease microglial volume. All treatments similarly decreased microglial number and increased microglial complexity after I/R injury (Fig 1) . Conclusions: Inhibition of apoptosis and ferroptosis, but not necroptosis, effectively reduced myocardial infarction and brain inflammation. Targeting these cell death pathways could be a novel strategy against brain injury due to cardiac I/R.
Title: Abstract 9484: Ferroptosis Inhibitors Reduce Brain Inflammation Due to Cardiac Ischemia/Reperfusion Injury in Rats
Description:
Introduction: Brain inflammation and microglial hyperactivation are involved in the process of neuronal death including apoptosis, necroptosis, and ferroptosis, following cardiac and cerebral ischemia/reperfusion (I/R) injury.
However, the roles of these cell death inhibitors on brain inflammation and microglia following cardiac I/R injury have not been investigated.
Hypothesis: Inhibitors of apoptosis, necroptosis and ferroptosis effectively attenuate brain inflammation and microglial hyperactivation in rats with cardiac I/R injury.
Methods: Rats were subjected to either sham or cardiac I/R operation (30 min-ischemia followed by 120-min reperfusion).
Rats in cardiac I/R group were divided into 4 treatment groups: 1) vehicle, 2) apoptosis inhibitor (Z-VAD; 3.
3 mg/kg), 3) necroptosis inhibitor (necrostatin-1; Nec-1; 3.
3 mg/kg), and 4) ferroptosis inhibitor (ferrostatin-1; Fer-1; 2 mg/kg).
These drugs were given intravenously at 15 min before ischemia.
Finally, the heart and brain tissues were removed and used to determine cardiac infarct size, hippocampal-microglial morphology, and levels of cortical inflammatory cytokines.
Results: Cardiac I/R injury caused myocardial infarction and brain inflammation as indicated by increased cortical IL-1β mRNA level and hippocampal microglial hyperactivation.
Treatment with Z-VAD and Fer-1, but not Nec-1, reduced myocardial infarction and cortical IL-1β mRNA level.
Z-VAD and Fer-1 also increased microglial process length and decreased microglial volume.
Nec-1 increased microglial process length, but it did not decrease microglial volume.
All treatments similarly decreased microglial number and increased microglial complexity after I/R injury (Fig 1) .
Conclusions: Inhibition of apoptosis and ferroptosis, but not necroptosis, effectively reduced myocardial infarction and brain inflammation.
Targeting these cell death pathways could be a novel strategy against brain injury due to cardiac I/R.

Related Results

Effects of simulated ischemia-reperfusion and atorvastatin on INa in rat left ventricular myocytes.
Effects of simulated ischemia-reperfusion and atorvastatin on INa in rat left ventricular myocytes.
Objective To observe time dependent effects of simulated ischemia-reperfusion on transient sodium currents (INa) in rat left ventricular myocytes, and effects of ...
Brain Organoids, the Path Forward?
Brain Organoids, the Path Forward?
Photo by Maxim Berg on Unsplash INTRODUCTION The brain is one of the most foundational parts of being human, and we are still learning about what makes humans unique. Advancements ...
Activation of Sensory Neurons Reduces Ischemia/Reperfusion-induced Acute Renal Injury in Rats
Activation of Sensory Neurons Reduces Ischemia/Reperfusion-induced Acute Renal Injury in Rats
Background Prostaglandin I2 (PGI2) produced by endothelial cells improves ischemia/reperfusion-induced acute renal injury by inhibiting leukocyte activation in rats. Ho...
Deferoxamine Alleviates Osteoarthritis by Inhibiting Chondrocyte Ferroptosis and Activating the Nrf2 Pathway
Deferoxamine Alleviates Osteoarthritis by Inhibiting Chondrocyte Ferroptosis and Activating the Nrf2 Pathway
Objective: Osteoarthritis (OA) is a common disease with a complex pathology including mechanical load, inflammation, and metabolic factors. Chondrocyte ferroptosis contributes to O...
GABAergic Signaling during Spinal Cord Stimulation Reduces Cardiac Arrhythmias in a Porcine Model
GABAergic Signaling during Spinal Cord Stimulation Reduces Cardiac Arrhythmias in a Porcine Model
Background Neuraxial modulation, including spinal cord stimulation, reduces cardiac sympathoexcitation and ventricular arrhythmogenesis. There is an incomplete understa...

Back to Top